Nutritional Gaps Linked to GLP-1 Weight Loss Drugs

By Prana IV Therapy

SCOTTSDALE, Ariz., May 21, 2026 /PRNewswire/ -- The rapid rise of GLP-1 medications such as semaglutide and tirzepatide has sparked discussion around the potential nutritional impact of these drugs as millions of patients use them for weight loss and diabetes management. Prana IV Therapy(opens in new tab), a Scottsdale-based wellness clinic, says increasing awareness around nutrient deficiencies associated with GLP-1 therapies(opens in new tab) has contributed to rising interest in nutritional monitoring and supplementation support.

 

Nutritional Gaps GLP-1

Read More >>>

BOOK NOW

Call or text anytime to book, or EARN UP TO 50 BONUS REWARDS POINTS* by booking online!

ONLINE

BOOKING WIZARD

CALL

480-202-4993

TEXT

480-202-4993

Posted in Blog, Prana News

About Prana IV Therapy

At Prana IV Therapy, each article and post goes through an internal review process between members of our medical team. This includes a DO, NP, RN and an IHPL2. This ensures the information is accurate and geared towards educating a general wellness audience. Before receiving care at Prana IV Therapy each client is screened by an in-house DO, MD, PA or NP, and receives individual orders. These articles are not intended as medical advice; please speak with your doctor before starting any new wellness therapies.